Menu

Search

Elizabeth M. Hofmeister

Elizabeth M. Hofmeister

Associate Professor of Surgery, Uniformed Services University of the Health Sciences
Dr. Hofmeister is a Pennsylvania native who has lived in Southern California since 1997, thanks to a 31-year career in the U.S Navy. The daughter of a registered nurse and a nurse anesthetist, Dr. Hofmeister set her sights on becoming a doctor during high school, and was one of a select few officers allowed to pursue a medical degree upon her graduation with distinction from the U.S. Naval Academy in 1989. She received her Doctorate of Medicine from the Uniformed Services University of the Health Sciences in 1993, and completed an Internal Medicine internship at the National Naval Medical Center in Bethesda. She then moved to Pensacola, Florida, where she received her Flight Surgery gold wings from the Naval Aerospace Medicine Institute, and then served as a flight surgeon on Marine Corps Base Hawaii for two years.

Her grandmother’s blindness from severe glaucoma and macular degeneration inspired her to seek a career in ophthalmology. She completed her ophthalmology residency training at Naval Medical Center San Diego, where she was among the Navy’s first surgeons trained to perform PRK and LASIK. She then pursued fellowship training in Cornea, External Disease, and Refractive Surgery at the prestigious Wills Eye Hospital in Philadelphia. Following fellowship training, she returned to Naval Medical Center San Diego, where she served as faculty until 2021. While on faculty, she deployed many times, including humanitarian missions on the hospital ship USNS Mercy, and a deployment to a combat zone in Afghanistan as the Deputy Command Surgeon of the Combined Security Transition Command in 2009. She has served in many leadership roles, including Ophthalmology Residency Program Director, Refractive Surgery Center Director, Ophthalmology Department Chairman, and the Navy’s Refractive Surgery Advisor from 2010 until 2020.

Dr. Hofmeister’s clinical interests as a Cornea Specialist include the treatment of dry eyes, viral and bacterial eye infections, and keratoconus. She performs cataract surgery, corneal crosslinking, full-thickness and partial-thickness (DSAEK, DMEK) corneal transplants. As a refractive surgeon, she has performed over 9,000 PRK, LASIK, and SMILE procedures, and is experienced with implantable collamer lens (ICL) surgery and refractive lens exchange. She is also one of the leading teachers of refractive surgery in the United States, having trained over 60 residents and fellows from three residency programs in her 21 years as a Navy Ophthalmologist.

An avid researcher, Dr. Hofmeister was an investigator on many studies of refractive surgery, with a focus on best practices, new technologies, and the safety of refractive surgery in patients with physically demanding jobs or austere work environments. She was the principal investigator on the landmark Patient-reported Outcomes with LASIK (PROWL) study, conducted with the FDA to assess patients’ satisfaction with LASIK.

Dr. Hofmeister is board-certified by the American Board of Ophthalmology, and is a member of the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, the Alpha Omega Alpha honor society, the Society of Military Ophthalmologists, and the American Society of Ocular Trauma. She is an Associate Professor of Surgery at the Uniformed Service University of the Health Sciences, and while in the Navy, held Adjunct Faculty Positions at the University of California San Diego, and Loma Linda University.

Some of her most gratifying moments have occurred during humanitarian surgical missions to Papua New Guinea, Fiji, the Philippines, and Honduras, where she performed manual small-incision cataract surgery, allowing patients formerly blind from cataracts to see their loved ones again. A highlight was her volunteer mission to Honduras, where her daughter provided Spanish translation with the surgical technicians in the operating room.

An accomplished vocalist and pianist, Dr. Hofmeister has performed with many amateur groups, and provides weekly music at her church. She loves hiking and travelling with her husband, who is also a physician.

1 

Economy

Dollar Slumps as Tariff Uncertainty Lifts Euro, Yen, and Swiss Franc

The U.S. dollar held steady on Wednesday but is set for its worst monthly decline since November 2022, falling sharply amid rising global uncertainty over President Donald Trumps volatile trade policies. Retreats from...

Oil Prices Dip Amid Tariff Concerns, Rising Inventories, and OPEC+ Output Worries

Oil prices slipped in early Asian trading Wednesday, pressured by renewed concerns over global economic growth and fuel demand due to U.S. tariff policies and rising crude inventories. Brent crude futures fell 17 cents, or...

U.S. Stock Futures Dip as Investors Monitor Trade Developments, Earnings, and Key Data

U.S. stock futures slipped Tuesday evening as investors digested signs of easing trade tensions, soft economic data, and awaited major corporate earnings. SP 500 futures fell 0.2% to 5,571.75, while Nasdaq 100 futures...

India Eyes Swift U.S. Trade Deal with Rare Forward MFN Clause

India is accelerating trade talks with the U.S., offering significant concessions to secure a fast-track deal ahead of President Donald Trumps proposed 26% reciprocal tariff deadline in July. According to Indian government...

Sweden’s Q1 2025 GDP Stalls, Missing Growth Forecasts

Swedens economy stagnated in the first quarter of 2025, with gross domestic product (GDP) showing no growth compared to the previous three months, according to preliminary data from the Statistics Office released Tuesday....

Politics

Carney's Liberals Win Canadian Election Amid Trump Tariff Backlash

Canadian Prime Minister Mark Carneys Liberal Party staged a political comeback, winning 169 electoral districts in Mondays parliamentary election, just shy of a majority. The result, driven by public backlash to U.S....

Trump Touts Economic Record, Promises Tax Cuts at Michigan Rally Amid Recession Fears

President Donald Trump rallied supporters in Warren, Michigan, marking his first 100 days in office with bold claims about the U.S. economy, promises of sweeping tax cuts, and sharp criticism of Democrats. Speaking near...

Tensions Escalate as China, U.S., and Philippines Conduct Rival Patrols in South China Sea

Chinas navy conducted a patrol in the South China Sea on Tuesday, accusing the Philippines of provocations as Filipino and U.S. forces carried out joint aerial patrols over the disputed waters. The move comes amid rising...

U.S. Defense Secretary Scraps Women, Peace and Security Program Citing Military Focus

U.S. Defense Secretary Pete Hegseth announced Tuesday the cancellation of the Women, Peace, and Security (WPS) program, originally enacted by President Donald Trump in 2017 to promote womens participation in global peace...

U.S. Urges India and Pakistan to Avoid Escalation After Kashmir Attack

U.S. Secretary of State Marco Rubio is set to hold talks with his Indian and Pakistani counterparts in an effort to prevent further escalation following a deadly militant attack in India-administered Kashmir. The State...

Science

Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global...

AstraZeneca’s Imfinzi Gets US Approval for Bladder Cancer Treatment

AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder cancer, a significant advancement in cancer therapy. The approval allows Imfinzi to be used in...

Sanofi’s New Hemophilia Drug Qfitlia Gains FDA Approval with Breakthrough Bimonthly Dosing

The U.S. Food and Drug Administration (FDA) has approved Qfitlia, a groundbreaking hemophilia treatment by French pharmaceutical giant Sanofi (NASDAQ: SNY). Designed for patients aged 12 and older with hemophilia A or B,...

FDA Vaccine Chief Peter Marks Resigns Amid Controversy Over Transparency

Peter Marks, the U.S. Food and Drug Administrations (FDA) top vaccine official, has resigned after reportedly being forced out by the Department of Health and Human Services (HHS), according to The Wall Street Journal....

Museums have tons of data, and AI could make it more accessible − but standardizing and organizing it across fields won’t be easy

Ice cores in freezers, dinosaurs on display, fish in jars, birds in boxes, human remains and ancient artifacts from long gone civilizations that few people ever see museum collections are filled with all this and more....

Technology

TSMC Expands U.S. Chip Production With Third Arizona Fab and $100B Investment Boost

Taiwan Semiconductor Manufacturing Co. (NYSE:TSM), the worlds largest contract chipmaker, has officially broken ground on its third semiconductor fabrication plant in Phoenix, Arizona. This marks a major milestone in the...

Meta Launches Standalone AI App to Compete with OpenAI and Google

Meta Platforms (NASDAQ:META) has released a standalone app for its Meta AI assistant, marking a significant step to boost its presence in the rapidly evolving AI market. Previously accessible only through Metas main...

Amazon Enters Satellite Internet Race with First Kuiper Deployment

Amazon (NASDAQ:AMZN) has officially entered the satellite broadband market with the successful launch of 27 operational satellites for Project Kuiper, its high-speed internet initiative aimed at rivaling SpaceXs Starlink....

Chinese AI App DeepSeek Resumes Downloads in South Korea After Privacy Update

Chinese artificial intelligence app DeepSeek has resumed availability in South Koreas app stores after a two-month suspension due to data protection concerns. Downloads were halted in February when South Koreas Personal...

Nvidia Shares Dip as Huawei Tests Rival AI Chip

Nvidia Corporation (NASDAQ: NVDA) slipped in after-hours trading on Sunday, following reports that Chinas Huawei is testing a powerful artificial intelligence chip aimed at challenging Nvidias dominance. NVDA shares fell...
  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.